TriangleFOR PATIENTS · SOURCE READING
Treatment of cutaneous T-cell lymphoma
Source: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Options for Childhood Non-Hodgkin Lymphoma / Rare NHL Occurring in Children
For information about the treatments listed below, see Treatment Option Overview.
Source links and citations
Treatment of subcutaneous panniculitis-like T-cell lymphoma in children may include:
Source links and citations
watchful waiting
immunotherapy using steroids with or without cyclosporine A or ruxolitinib
Source links and citations
targeted therapy (denileukin diftitox)
Source links and citations
combination chemotherapy
retinoid therapy
Source links and citations
stem cell transplant
Source links and citations
Treatment of cutaneous anaplastic large cell lymphoma may include surgery, radiation therapy, or both.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice